{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:41:12Z","timestamp":1776602472273,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06217-3","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:52:00Z","timestamp":1768809120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and external validation of a nomogram predicting cancer-specific mortality-free survival after trimodal therapy in muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"44","author":[{"given":"Mattia","family":"Longoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Falkenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Marmiroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quynh Chi","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Nicolazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calogero","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Polverino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K. H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"6217_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2024.09.013","author":"M de Angelis","year":"2024","unstructured":"de Angelis M, Siech C, Di Bello F, Pe\u00f1aranda NR, Goyal JA, Tian Z et al Survival rates in trimodal therapy versus radiotherapy in urothelial carcinoma of urinary bladder. Eur Urol Focus. 2024.https:\/\/doi.org\/10.1016\/j.euf.2024.09.013","journal-title":"Eur Urol Focus"},{"key":"6217_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2024.11.003","author":"A Matsukawa","year":"2024","unstructured":"Matsukawa A, Yanagisawa T, Miszczyk M, Parizi MK, Fazekas T, Tsuboi I et al Trimodality therapy versus radical cystectomy for muscle-invasive bladder cancer: a systematic review and meta-analysis of matched cohort studies. Eur Urol Focus 2024. https:\/\/doi.org\/10.1016\/j.euf.2024.11.003","journal-title":"Eur Urol Focus"},{"key":"6217_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.02.019","author":"AG van der Heijden","year":"2025","unstructured":"van der Heijden AG, Bruins HM, Carrion A, Cathomas R, Comp\u00e9rat E, Dimitropoulos K et al (2025) European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 guidelines. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.019","journal-title":"Eur Urol"},{"key":"6217_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16622","author":"M Longoni","year":"2024","unstructured":"Longoni M, Di Bello F, Rodriguez Pe\u00f1aranda N, Falkenbach F, Marmiroli A, Le QC et al (2024) Survival after trimodal therapy in octogenarians with organ-confined urothelial bladder cancer. BJU Int. https:\/\/doi.org\/10.1111\/bju.16622","journal-title":"BJU Int"},{"key":"6217_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2025.02.051","author":"M Longoni","year":"2025","unstructured":"Longoni M, Pe\u00f1aranda NR, Marmiroli A, Falkenbach F, Le QC, Nicolazzini M et al (2025) Survival outcomes and temporal trends of non-surgical management vs radical cystectomy in non-organ-confined urothelial bladder cancer. Urology. https:\/\/doi.org\/10.1016\/j.urology.2025.02.051","journal-title":"Urology"},{"key":"6217_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","volume":"24","author":"AR Zlotta","year":"2023","unstructured":"Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G et al (2023) Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. Lancet Oncol 24:669\u201381. https:\/\/doi.org\/10.1016\/S1470-2045(23)00170-5","journal-title":"Lancet Oncol"},{"key":"6217_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jso.70014","author":"M Longoni","year":"2025","unstructured":"Longoni M, Marmiroli A, Falkenbach F, Le QC, Nicolazzini M, Catanzaro C et al (2025) Cancer-specific survival of trimodal therapy versus radical cystectomy in T2N0M0 non\u2010urothelial bladder cancer. J Surg Oncol. https:\/\/doi.org\/10.1002\/jso.70014","journal-title":"J Surg Oncol"},{"key":"6217_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijrobp.2013.01.020","volume":"86","author":"JJ Coen","year":"2013","unstructured":"Coen JJ, Paly JJ, Niemierko A, Kaufman DS, Heney NM, Spiegel DY et al (2013) Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 86:311\u20136. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.01.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6217_CR9","unstructured":"AJCC Cancer Staging Manual (2017) 8th ed. Springer"},{"key":"6217_CR10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.euf.2023.03.014","volume":"9","author":"ML Piccinelli","year":"2023","unstructured":"Piccinelli ML, Barletta F, Tappero S, Cano Garcia C, Incesu R-B, Morra S et al (2023) Development and external validation of a novel nomogram predicting cancer-specific mortality\u2013free survival in surgically treated papillary renal cell carcinoma patients. Eur Urol Focus 9:799\u2013806. https:\/\/doi.org\/10.1016\/j.euf.2023.03.014","journal-title":"Eur Urol Focus"},{"key":"6217_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y (2005) Survival model predictive accuracy and ROC curves. Biometrics 61:92\u2013105. https:\/\/doi.org\/10.1111\/j.0006-341X.2005.030814.x","journal-title":"Biometrics"},{"key":"6217_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26:565\u201374. https:\/\/doi.org\/10.1177\/0272989X06295361","journal-title":"Med Decis Making"},{"key":"6217_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/bju.16333","volume":"134","author":"M de Angelis","year":"2024","unstructured":"de Angelis M, Baudo A, Siech C, Jannello LMI, Di Bello F, Goyal JA et al (2024) Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer. BJU Int 134:602\u20137. https:\/\/doi.org\/10.1111\/bju.16333","journal-title":"BJU Int"},{"key":"6217_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS16071292","author":"M de Angelis","year":"2024","unstructured":"de Angelis M, Baudo A, Siech C, Jannello LMI, Di Bello F, Goyal JA et al (2024) Non-surgical bladder-sparing multimodal management in organ-confined urothelial carcinoma of the urinary bladder: a population-based analysis. Cancers. https:\/\/doi.org\/10.3390\/CANCERS16071292","journal-title":"Cancers"},{"key":"6217_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102119","volume":"22","author":"M de Angelis","year":"2024","unstructured":"de Angelis M, Scheipner L, Siech C, Jannello LMI, Baudo A, Bello FD et al (2024) Temporal trends and cancer-specific mortality in nonmetastatic muscle-invasive urothelial carcinoma of the urinary bladder treated with trimodal therapy. Clin Genitourin Cancer 22:102119. https:\/\/doi.org\/10.1016\/j.clgc.2024.102119","journal-title":"Clin Genitourin Cancer"},{"key":"6217_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-024-01973-7","author":"M de Angelis","year":"2024","unstructured":"de Angelis M, Baudo A, Siech C, Jannello LMI, Di Bello F, Goyal JA et al (2024) The effect of race\/ethnicity on cancer-specific mortality after trimodal therapy. J Racial Ethn Health Disparities. https:\/\/doi.org\/10.1007\/s40615-024-01973-7","journal-title":"J Racial Ethn Health Disparities"},{"key":"6217_CR17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/bju.16363","volume":"134","author":"M Longoni","year":"2024","unstructured":"Longoni M, Scilipoti P, Re C, Rosiello G, Nocera L, Pellegrino F et al (2024) Use of 18F-fluoro-2-deoxy-D-glucose (18F-FDG) PET\/CT for lymph node assessment before radical cystectomy in bladder cancer patients. BJU Int 134:636\u201343. https:\/\/doi.org\/10.1111\/bju.16363","journal-title":"BJU Int"},{"key":"6217_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.euo.2024.09.011","volume":"8","author":"F Liedberg","year":"2025","unstructured":"Liedberg F, Mariappan P, Gontero P (2025) Clinical implementation of urinary biomarkers for surveillance of non\u2013muscle-invasive bladder cancer (NMIBC): considerations from the European association of urology NMIBC guideline panel. Eur Urol Oncol 8:234\u2013236. https:\/\/doi.org\/10.1016\/j.euo.2024.09.011","journal-title":"Eur Urol Oncol"},{"key":"6217_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eururo.2024.08.033","volume":"87","author":"L Afferi","year":"2025","unstructured":"Afferi L, Cimadamore A, Gallioli A, Pradere B, Mertens LS, Marcq G et al (2025) Tissue-based biomarkers steering clinical decisions in patients with urothelial cancer. Eur Urol 87:1\u20134. https:\/\/doi.org\/10.1016\/j.eururo.2024.08.033","journal-title":"Eur Urol"},{"key":"6217_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.euo.2018.08.009","volume":"2","author":"M Bandini","year":"2019","unstructured":"Bandini M, Briganti A, Plimack ER, Niegisch G, Yu EY, Bamias A et al (2019) Modeling 1-year relapse-free survival after neoadjuvant chemotherapy and radical cystectomy in patients with clinical T2-4N0M0 urothelial bladder carcinoma: endpoints for phase 2 trials. Eur Urol Oncol 2:248\u201356. https:\/\/doi.org\/10.1016\/j.euo.2018.08.009","journal-title":"Eur Urol Oncol"},{"key":"6217_CR21","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1245\/s10434-025-17488-2","volume":"32","author":"M Longoni","year":"2025","unstructured":"Longoni M, Marmiroli A, Falkenbach F, Le QC, Nicolazzini M, Catanzaro C et al (2025) Cancer-specific mortality of partial cystectomy versus radical cystectomy in T2N0M0 urothelial bladder cancer. Ann Surg Oncol 32:6133\u201340. https:\/\/doi.org\/10.1245\/s10434-025-17488-2","journal-title":"Ann Surg Oncol"},{"key":"6217_CR22","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1007\/s11255-025-04566-3","volume":"57","author":"M Longoni","year":"2025","unstructured":"Longoni M, Marmiroli A, Falkenbach F, Le QC, Nicolazzini M, Catanzaro C et al (2025) Oncological outcomes after non-surgical management versus radical cystectomy in non-organ-confined non-urothelial bladder cancer. Int Urol Nephrol 57:3639\u201346. https:\/\/doi.org\/10.1007\/s11255-025-04566-3","journal-title":"Int Urol Nephrol"},{"key":"6217_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.eururo.2025.03.017","volume":"89","author":"S Gupta","year":"2026","unstructured":"Gupta S, Hensley PJ, Li R, Choudhury A, Daneshmand S, Faltas BM et al (2026) Bladder preservation strategies in muscle-invasive bladder cancer: recommendations from the international bladder cancer group. Eur Urol 89:18\u201328. https:\/\/doi.org\/10.1016\/j.eururo.2025.03.017","journal-title":"Eur Urol"},{"key":"6217_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.euf.2023.06.014","volume":"10","author":"R Sari Motlagh","year":"2024","unstructured":"Sari Motlagh R, Ghoreifi A, Yanagisawa T, Kawada T, Kikic Z, Gill I et al (2024) Survival of patients with chronic kidney disease treated with radical cystectomy and risk factors of glomerular filtration rate loss following radical cystectomy: two systematic reviews and meta-analyses of interplay between radical cystectomy and renal function. Eur Urol Focus 10:169\u201381. https:\/\/doi.org\/10.1016\/j.euf.2023.06.014","journal-title":"Eur Urol Focus"}],"updated-by":[{"DOI":"10.1007\/s00345-026-06359-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000}}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06217-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06217-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06217-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T11:59:25Z","timestamp":1776599965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06217-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6217"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06217-3","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00345-026-06359-4","URL":"https:\/\/doi.org\/10.1007\/s00345-026-06359-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"111"}}